Corcept Therapeutics Incorporated
CORT
$33.43
$0.130.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.29M | 19.67M | 35.15M | 20.55M | 30.75M |
| Total Depreciation and Amortization | 482.00K | 477.00K | 469.00K | 462.00K | 460.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.49M | 30.99M | -53.00K | 6.43M | 10.75M |
| Change in Net Operating Assets | 9.19M | 3.35M | 8.37M | -22.31M | 18.11M |
| Cash from Operations | 38.45M | 54.48M | 43.94M | 5.13M | 60.06M |
| Capital Expenditure | -50.00K | 0.00 | -57.00K | -104.00K | -121.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.79M | 14.65M | 70.18M | -3.07M | -64.24M |
| Cash from Investing | -11.84M | 14.65M | 70.13M | -3.17M | -64.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.32M | 4.20M | 12.51M | 3.46M | 2.42M |
| Repurchase of Common Stock | -36.54M | -50.62M | -115.44M | -43.26M | -6.99M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.22M | -46.41M | -102.93M | -39.80M | -4.56M |
| Foreign Exchange rate Adjustments | -32.00K | -320.00K | 1.79M | -- | -758.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.64M | 22.39M | 12.93M | -37.85M | -9.62M |